Viking Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 30 U.S.-traded ETFs. VKTX has around 6.4M shares in the U.S. ETF market. The largest ETF holder of VKTX is the SPDR S&P Biotech ETF (XBI), with approximately 3.13M shares. Investors may also find of interest that the ETF with the largest allocation to VKTX stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 0.65%. On average, U.S. ETFs allocate 0.09% of VKTX to their portfolios.
Additionally, VKTX is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VKTX as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.59%.